Grant of Stock Compensation-Type Stock Acquisition Rights to Directors
First written in FY2019-Q2. 2 of 3 entries say "Advanced", first in FY2020-Q2. Latest entry: FY2021-Q2.
- FY2021-Q2AdvancedAnnual report
「12th Series of Stock Compensation-Type Stock Acquisition Rights Date of resolution 14 July 2020 Category and number of eligible recipients 5 directors of the company (excluding outside directors) Number of stock acquisition rights (rights)* 1,054 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 105,400 (Note 1) Exercise period for the stock acquisition rights* From 21 August 2020 To 20 August 2050」
The company granted 1,054 12th Series stock compensation-type stock acquisition rights, representing 105,400 underlying shares, to 5 directors excluding outside directors. - FY2020-Q2AdvancedAnnual report
「11th Series of Stock Compensation-Type Stock Acquisition Rights Date of resolution 19 July 2019 Category and number of eligible recipients 13 directors of the company (excluding outside directors) Number of stock acquisition rights (rights)* 1,290 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 129,000 (Note 1) Exercise period for the stock acquisition rights* From 23 August 2019 To 22 August 2049」
The company newly granted 1,290 11th Series stock compensation-type stock acquisition rights, representing 129,000 underlying shares, to 13 directors excluding outside directors. - FY2019-Q2First statedAnnual report
「10th Series of Stock Compensation-Type Stock Acquisition Rights Date of resolution 10 July 2018 Category and number of eligible recipients 13 directors of the company (excluding outside directors) Number of stock acquisition rights (rights)* 1,060 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 106,000 (Note 1) Exercise period for the stock acquisition rights* From 9 August 2018 To 8 August 2048」
The company granted 1,060 stock compensation-type stock acquisition rights, representing 106,000 underlying shares, to 13 directors excluding outside directors. The exercise period runs from 9 August 2018 to 8 August 2048.